Skip to main content

Table 1 Clinical features and outcomes of the SARS-CoV-2 Omicron variant encephalopathy and the non-encephalopathy group

From: Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study

No. (%)

SARS-CoV-2 Encephalopathy

(N = 14)

SARS-CoV-2 Non-encephalopathy

(N = 102)

P

Age (year), mean ± SD

5.1 ± 3.4

2.6 ± 1.8

0.0049*

Sex (male) — n (%)

9 (64.3%)

65 (63.7%)

0.3333

Febrile seizure history— n (%)

3 (21.4%)

21 (20.6%)

 > 0.9999

SARS-CoV-2 vaccination history – n (%)

1 (7.1%)

6 (1%)

 > 0.9999

Vital sign (mean ± SD)

   

 Bradycardia n(%)

4 (28.6%)

0 (0%)

0.0001

 Hypotension n (%)

2 (14.3%)

0 (0%)

0.0136

 BT (°C)

39.6 ± 1.3A

39.5 ± 0.8a

0.6476

 HR initial (beats/min)

129 ± 42A

155 ± 26a

0.0261*

 RR initial (breaths/min)

22 ± 3.2A

25 ± 3.4a

0.5842

 SBP initial (mmHg)

106 ± 28B

112 ± 19b

0.2311

 DBP initial (mmHg)

61 ± 30B

75 ± 20b

0.0741

Systems Involvement — n (%)

   

 Respiratory

7 (50.0%)

64 (62.7%)

0.3912

 Gastrointestinal

6 (42.9%)

26 (25.5)

0.2056

 Cardiovascular ‡

3 (21.4%)

0 (0%)

0.0014*

 No. of involved system

2

2

0.1328

 Interval between fever and seizure (days) (mean ± SD)

1.6 ± 1.4

0.7 ± 0.9

0.0013*

Seizure types — n (%)

   

 GTCs

12(85.7%)

87(85.3%)

 > 0.9999

 Focal seizure

2 (14.3%)

2(2.0%)

0.0708

 Cluster (> 1 in 24 h)

7 (50.0%)

17 (16.7%)

0.0090*

 Status Epilepticus

7(50.0%)

14 (13.7%)

0.0037*

 Prolong (> 15 min)

3(21.4%)

2 (2.0%)

0.0123*

Encephalopathy — n (%)

   

 Initial GCS (mean)

11.7

14.9

 < 0.0001*

 Conscious disturbance§

11 (78.6%)

3 (2.9%)

 < 0.0001*

 Disorientation

3 (21.4%)

0 (0%)

0.0014*

 Hallucination

4 (28.6%)

0 (0%)

0.0001*

 Acute psychosis

2 (21.4%)

0 (0%)

0.0136*

Initial Severity — n (%)

  

 < 0.0001*

 Discharge from ED

1 (7.1%)

66 (64.7%)

 

 Admission to Ward

5 (35.7%)

36 (35.3%)

 

 Admission to ICU

8 (57.1%)

0 (0%)

 

Outcome — n (%)

  

 < 0.0001*

 Full recovered

9 (64.3%)

100 (98.0%)

 

 Neurological Sequelae&

4 (28.6%)

2 (2.0%)

 

 Death ††

1(7.1%)

0 (0%)

 

Laboratory (mean ± SD)

   

 WBC (/μL)

7142 ± 3477

7848 ± 3306

0.1957

 CRP (mg/L)

3.9 ± 5.3

4.3 ± 6.5

0.2808

 Sugar (mg/dL)

146 ± 35.6

108 ± 24.2

0.0229*

 pH

7.29 ± 0.11

7.39 ± 0.06

0.0018*

 pCO2 (mmHg)

40.2 ± 8.9

35.9 ± 7.2

0.0780

 HCO3−(mmHg)

19.5 ± 5.3

20.7 ± 2.2

0.9180

  1. Abbreviations: BT Body temperature, CRP C-reactive protein, DBP Diastolic blood pressure, ED Emergency department, GCS Glasgow Coma Scale, GTCs Generalized tonic–clonic seizures, HR Heart rate, ICU Intensive care unit, RR Respiration rate, SBP Systolic blood pressure, SD Standard deviation, WBC White blood cell; Delta-vital sign (HR, RR, SBP, DBP): subtract vital sign after treatment from vital sign before treatment
  2. *Statistically significance: P < 0.05, ‡ Cardiovascular symptoms included: bradycardia (n = 2), and hypotension (n = 3), & Neurological Sequelae: irritable (n = 2), headache (n = 1), slow response (n = 1) in acute encephalopathy group, poor appetite (n = 2) in non-encephalopathy group, †† Etiology of death: acute fulminant cerebral edema
  3. Different cohort numbers due to missing values were represented by: AN = 11, a N = 100; B N = 8, b N = 54